indomethacin has been researched along with Blood Loss, Postoperative in 4 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rectal indomethacin has been proven to be effective for prevention of post-ERCP pancreatitis (PEP) but its impact on bleeding after biliary sphincterotomy (BABES) and cardiovascular mortality has not been extensively studied." | 9.19 | Does rectal indomethacin given for prevention of post-ERCP pancreatitis increase bleeding after biliary endoscopic sphincterotomy or cardiovascular mortality?: Post hoc analysis using prospective clinical trial data. ( Patai, Á; Patai, ÁV; Solymosi, N, 2014) |
| "Rectal indomethacin has been proven to be effective for prevention of post-ERCP pancreatitis (PEP) but its impact on bleeding after biliary sphincterotomy (BABES) and cardiovascular mortality has not been extensively studied." | 5.19 | Does rectal indomethacin given for prevention of post-ERCP pancreatitis increase bleeding after biliary endoscopic sphincterotomy or cardiovascular mortality?: Post hoc analysis using prospective clinical trial data. ( Patai, Á; Patai, ÁV; Solymosi, N, 2014) |
| "Indomethacin is a known immune modulator that inhibits cyclooxygenase." | 2.73 | Pharmacological prevention of the deleterious effects of cardiopulmonary bypass. ( Afrakhteh, M; Givtaj, N; Hassantash, SA; Omrani, GR, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krill, T | 1 |
| Li, D | 1 |
| Sood, A | 1 |
| Baliss, M | 1 |
| Abrol, R | 1 |
| Zaibaq, J | 1 |
| Parupudi, S | 1 |
| Patai, Á | 1 |
| Solymosi, N | 1 |
| Patai, ÁV | 1 |
| Hassantash, SA | 1 |
| Omrani, GR | 1 |
| Givtaj, N | 1 |
| Afrakhteh, M | 1 |
| Dodenhoff, RM | 1 |
2 trials available for indomethacin and Blood Loss, Postoperative
| Article | Year |
|---|---|
Does rectal indomethacin given for prevention of post-ERCP pancreatitis increase bleeding after biliary endoscopic sphincterotomy or cardiovascular mortality?: Post hoc analysis using prospective clinical trial data.
Topics: Administration, Rectal; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C | 2014 |
Pharmacological prevention of the deleterious effects of cardiopulmonary bypass.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Coagulation; C-Reactive Protein; Cardiac Surgical Pro | 2007 |
2 other studies available for indomethacin and Blood Loss, Postoperative
| Article | Year |
|---|---|
Pharmacologic venous thromboembolism prophylaxis is not associated with post sphincterotomy bleeding after endoscopic retrograde cholangiopancreatography.
Topics: Adult; Aged; Anticoagulants; Case-Control Studies; Cholangiopancreatography, Endoscopic Retrograde; | 2021 |
Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Synergism; Hepa | 1996 |